<DOC>
	<DOCNO>NCT01291537</DOCNO>
	<brief_summary>The goal multicentric prospective randomize control clinical economic study investigate effectiveness cost-utility long-term continuous intraduodenal infusion levodopa ( DUODOPA ) , compare best medical treatment , advance severe form Parkinson 's disease .</brief_summary>
	<brief_title>Clinical Economic Impact Duodopa : Long-term Effectiveness Study Advanced Parkinson 's Disease Patients</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<criteria>Inclusion criterion : Age &gt; 18 year ≤ 80 year Akinetohypertonic and/or tremor form Parkinson 's disease define criterion French National Consensus conference Parkinson 's disease ( March 2000 ) Absence parkinsonism Parkinson 's disease , include absence one follow sign : autonomic syndrome , hallucination , pyramidal sign , early postural instability , early cognitive impairment ( include apraxia severe frontal lobe syndrome ) ( Consensus Conference , March 2000 ) Severe advance form Parkinson 's disease sensitivity Ldopa ( ≥ 40 % ) No contraindication Duodopa® : hypersensitivity levodopa carbidopa , excipients , angleclosure glaucoma , kidney liver failure , severe heart failure , severe cardiac arrhythmia , acute stroke , pheochromocytoma , hyperthyroidism , Cushing syndrome , association nonselective MAOIs selective MAOIsA ( stop least 2 week initiation Duodopa® ) Fluctuations motor performance ( OFF time ≥ 2 hour per day ) and/or dyskinesia induce LDOPA alter significantly activity daily life spite optimize treatment Hoehn Yahr score &lt; 4 best ON Ability complete diary selfevaluation ( help another person necessary ) MMSE ≥ 24/30 No evolutive psychosis history severe psychosis require hospitalization No digestive disease ENT evolutionary No concomitant treatment continuous infusion apomorphine No concomitant treatment deep brain stimulation No serious somatic disease likely interfere good participation study , contraindication gastrostomy Menopause prove woman childbearing potential effective contraception ( hormonal / mechanical : oral , injectable , transdermal , implantable , intrauterine device , surgery : ligation fallopian tube , hysterectomy , total ovariectomy ) Age &lt; 18 &gt; 80 year No signature inform consent form Patient social insurance benefit third person accordance French law biomedical research Population enhance protection ( i.e minor ) , pregnant woman , breastfeed woman , person deprive liberty judicial administrative decision , people health social service , adults legal protection , finally patient emergency situation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Advanced</keyword>
	<keyword>Severe form</keyword>
</DOC>